In a recent study published in The Lancet Digital Health, researchers discuss the development and validation of a combined model comprising imaging, clinical, and cell-free deoxyribonucleic acid (DNA) ...
News-Medical.Net on MSN
Integrating AI into colon cancer diagnosis improves the speed and accuracy of detection
A recent study reveals that integrating Artificial Intelligence (AI) into colon cancer diagnosis over the past five years has ...
BUFFALO, NY- July 21, 2023 – A new editorial paper was published in Oncoscience (Volume 10) on June 9, 2023, entitled, “Transforming early cancer detection in primary care: harnessing the power of ...
CNW/ - Syantra, Inc., a biotechnology company revolutionizing cancer detection, is announcing Scottsdale, Arizona based ...
A new cfDNA-based blood test uses AI to detect bladder, prostate, and kidney cancers early, offering a faster, safer, and ...
Following PRISMA guidelines, we performed a systematic literature review of the aforementioned statistical and ML models published between January 2008 and December 2022 through searching five digital ...
FANSS study data presented at ESMO Asia 2025 demonstrate the feasibility of screening Asian women who do not smokePALO ALTO, Calif., Dec. 5, 2025 /PRNewswire/ -- DELFI Diagnostics, Inc., developer of ...
The field of cancer immunology has experienced remarkable advancements in diagnostic capabilities, largely due to the integration of multispectral and hyperspectral imaging technologies. These imaging ...
Dealbreaker on MSN
Liquid biopsy firm Freenome finds a way to the public markets via $330M SPAC merger
Freenome’s SPAC merger agreement comes as the liquid biopsy developer prepares for potential 2026 commercialization of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback